Answers are grounded in this paper and cite their sources.
Animal study demonstrates that antiviral HPMPC prevents cytomegalovirus-enhanced graft atherosclerosis in rats, indicating viral replication directly accelerates chronic vascular rejection.
Effects of acute cytomegalovirus (CMV) infections on transplantation-associated atherosclerosis (TxAA) were studied in a rat model for chronic vascular rejection. Rats underwent orthotopic abdominal allogeneic aorta transplantation. Neo-intima formation and media thinning was quantitated by measurement of cross-sectional surface areas (CSA) at day 50 post transplantation (Tx). Acute rat cytomegalovirus (RCMV) infection, established at the moment of maximum intimal proliferation and influx of inflammatory cells in the adventitia, resulted in enhanced neo-intima formation, accompanied by increased influx and proliferation of smooth muscle cells (smc) in the intima. This effect was completely inhibited by HPMPC, a very potent and selective inhibitor of CMV replication, indicating the virus specificity of the measured effects. Despite increased neointima formation, media thinning ("necrosis") was not affected by RCMV infection.
No takes yet. Share an insight, caveat, or question.
BRUNING et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: